Turk Ilac ve Serumnayi (IST:TRILC) ROE % Adjusted to Book Value: 13.85% (As of Sep. 2025)


IST:TRILC Turk Ilac ve Serum Sanayi IST:TRILC
61 GF Score
Price ₺1.18
GF Value ₺3.60
Valuation Possible Value Trap
! 11 Warning Signs
View Full Analysis

What is Turk Ilac ve Serumnayi ROE % Adjusted to Book Value?

Turk Ilac ve Serumnayi IST:TRILC -2.48% 61 ROE % Adjusted to Book Value is 13.85% as of Sep. 2025. GuruFocus rates IST:TRILC with a GF Score™ of 61/100 and a GF Value™ of ₺3.60 (Possible Value Trap). The stock has 11 warning signs investors should review.

Turk Ilac ve Serumnayi's ROE % for the quarter that ended in Sep. 2025 was 26.59%. Turk Ilac ve Serumnayi's PB Ratio for the quarter that ended in Sep. 2025 was 1.92. Turk Ilac ve Serumnayi's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2025 was 13.85%.

Turk Ilac ve Serumnayi ROE % Adjusted to Book Value Related Terms

Turk Ilac ve Serumnayi ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for Turk Ilac ve Serumnayi's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Turk Ilac ve Serumnayi ROE % Adjusted to Book Value Chart

Turk Ilac ve Serumnayi Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
ROE % Adjusted to Book Value
0.00 2.70 -5.75 10.30 2.77

Turk Ilac ve Serumnayi Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.21 -3.02 -32.07 -30.97 13.85

IST:TRILC vs ZTS, UTHR, VTRS: ROE % Adjusted to Book Value Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Turk Ilac ve Serumnayi's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Turk Ilac ve Serumnayi ROE % Adjusted to Book Value vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Turk Ilac ve Serumnayi's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Turk Ilac ve Serumnayi's ROE % Adjusted to Book Value falls into.


IST:TRILC
61GF Score
Turk Ilac ve Serum Sanayi IST:TRILC
ROE % Adjusted to Book Value is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Turk Ilac ve Serumnayi ROE % Adjusted to Book Value Calculation

Turk Ilac ve Serumnayi's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=3.91% / 1.41
=2.77%

Turk Ilac ve Serumnayi's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2025 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=26.59% / 1.92
=13.85%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROE % Adjusted to Book Value of 13.85% mean?
Turk Ilac ve Serumnayi (IST:TRILC) has a ROE % Adjusted to Book Value of 13.85% as of Sep. 2025. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Turk Ilac ve Serumnayi and its competitors.
Is Turk Ilac ve Serumnayi's ROE % Adjusted to Book Value too high?
Turk Ilac ve Serumnayi's current ROE % Adjusted to Book Value is 13.85%. Overall, Turk Ilac ve Serumnayi has a GF Score™ of 61/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Turk Ilac ve Serumnayi's ROE % Adjusted to Book Value compare to ZTS and UTHR?
Turk Ilac ve Serumnayi's ROE % Adjusted to Book Value of 13.85% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Drug Manufacturers company?
A good ROE % Adjusted to Book Value depends on the Drug Manufacturers industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Turk Ilac ve Serumnayi and its competitors. Turk Ilac ve Serumnayi's current ROE % Adjusted to Book Value is 13.85%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Turk Ilac ve Serumnayi stock overvalued right now?
Based on GuruFocus' analysis, Turk Ilac ve Serumnayi (IST:TRILC) is currently considered Possible Value Trap. The stock's GF Value™ is ₺3.60, compared to a current price of ₺1.18 — trading 67.2% below its estimated fair value. The current ROE % Adjusted to Book Value is 13.85%. Turk Ilac ve Serumnayi's overall GF Score™ is 61/100 with 11 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Turk Ilac ve Serumnayi (IST:TRILC), the current ROE % Adjusted to Book Value is 13.85% as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Turk Ilac ve Serumnayi (IST:TRILC) Overvalued in 2026?

Based on GuruFocus' analysis, Turk Ilac ve Serumnayi stock appears to be undervalued. The current stock price of ₺1.18 is trading 67.2% below its estimated GF Value™ of ₺3.60. GuruFocus considers Turk Ilac ve Serumnayi to be Possible Value Trap.

Key valuation signals for IST:TRILC:

  • ROE % Adjusted to Book Value: 13.85%
  • GF Value™: ₺3.60 vs. price of ₺1.18 (67.2% below fair value)
  • GF Score™: 61/100 with 11 warning signs

No single metric tells the full story. See the IST:TRILC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Turk Ilac ve Serumnayi Business Description

Address Bugduz Mahalle Enver Pasa Cadde, No: 8 Akyurt, Ankara, TUR, TR 06750
Turk Ilac ve Serum Sanayi is engaged in the production of human pharmaceuticals and vaccines.
61GF Score

Get the complete analysis for IST:TRILC

ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₺1.18
Price
₺3.60
GF Value